Rb. Myers et al., Fatty acid synthase: An early molecular marker of progression of prostaticadenocarcinoma to androgen independence, J UROL, 165(3), 2001, pp. 1027-1032
Purpose: Changes in fatty acid synthase levels were investigated in the CWR
22 xenograft model of prostatic adenocarcinoma after castration and during
progression to androgen independence.
Materials and Methods: Male nude mice with CWR22 tumors were castrated and
sacrificed 3, 7, 21, 28 or 42 days after castration. Some mice received tes
tosterone replenishment 21 days after castration and were sacrificed 7 days
later. In addition, other castrates were maintained for 7 to 10 months to
allow tumors to relapse to androgen independence. Fatty acid synthase was m
easured by immunohistochemical study and Western blot analysis.
Results: Fatty acid synthase decreased rapidly after castration and after 2
8 to 42 days it was 5% to 10% of the level in tumors of intact controls. Te
mporal changes in fatty acid synthase after castration were associated with
decreased proliferative potential and increased levels of the cyclin depen
dent kinase inhibitor p27Kip-1. Testosterone treatment of castrates at 21 t
o 28 days after castration increased fatty acid synthase expression to the
level in tumors of intact controls. Tumors of long-term castrates with post
-castration androgen independent growth had increased fatty acid synthase,
as did small focal areas of androgen independent proliferation in tumors th
at had not increased in size by 7 to 10 months. In relapsed CWR22 tumors an
d in focal areas of androgen independent proliferation in nonrelapsed CWR22
tumors increased fatty acid synthase was associated spatially with increas
ed proliferation and decreased p27Kip-1.
Conclusions: Fatty acid synthase in CWR22 tumors depends initially on testo
sterone and it is associated with androgen mediated proliferation. Furtherm
ore, increased fatty acid synthase levels associated with androgen independ
ent proliferation may represent an early event in the development of the an
drogen independent phenotype.